title: Intracellular trafficking of silicon particles and logic-embedded vectors.
abstract: Mesoporous silicon particles show great promise for use in drug delivery and imaging applications as carriers for second-stage nanoparticles and higher order particles or therapeutics. Modulation of particle geometry, surface chemistry, and porosity allows silicon particles to be optimized for specific applications such as vascular targeting and avoidance of biological barriers commonly found between the site of drug injection and the final destination. In this study, the intracellular trafficking of unloaded carrier silicon particles and carrier particles loaded with secondary iron oxide nanoparticles was investigated. Following cellular uptake, membrane-encapsulated silicon particles migrated to the perinuclear region of the cell by a microtubule-driven mechanism. Surface charge, shape (spherical and hemispherical) and size (1.6 and 3.2 microm) of the particle did not alter the rate of migration. Maturation of the phagosome was associated with an increase in acidity and acquisition of markers of late endosomes and lysosomes. Cellular uptake of iron oxide nanoparticle-loaded silicon particles resulted in sorting of the particles and trafficking to unique destinations. The silicon carriers remained localized in phagosomes, while the second stage iron oxide nanoparticles were sorted into multi-vesicular bodies that dissociated from the phagosome into novel membrane-bound compartments. Release of iron from the cells may represent exocytosis of iron oxide nanoparticle-loaded vesicles. These results reinforce the concept of multi-functional nanocarriers, in which different particles are able to perform specific tasks, in order to deliver single- or multi-component payloads to specific sub-cellular compartments.
authors.affiliation: University of Texas Health Science Center, Department of NanoMedicine and Biomedical Engineering, 1825 Pressler Street, Suite 537, Houston, TX 77030, USA.
authors.forename: Silvia
authors.initials: S
authors.lastname: Ferrati
authors.forename: Aaron
authors.initials: A
authors.lastname: Mack
authors.forename: Ciro
authors.initials: C
authors.lastname: Chiappini
authors.forename: Xuewu
authors.initials: X
authors.lastname: Liu
authors.forename: Andrew J
authors.initials: AJ
authors.lastname: Bean
authors.forename: Mauro
authors.initials: M
authors.lastname: Ferrari
authors.forename: Rita E
authors.initials: RE
authors.lastname: Serda
mesh_terms: D002462:Cell Membrane / Q000378:metabolism; D004337:Drug Carriers / Q000737:chemistry; D042783:Endothelial Cells / Q000378:metabolism; D004730:Endothelium, Vascular / Q000166:cytology; D005290:Ferric Compounds / Q000737:chemistry; D006801:Humans; D053768:Metal Nanoparticles / Q000008:administration & dosage* / Q000737:chemistry; D046529:Microscopy, Electron, Transmission; D008870:Microtubules / Q000378:metabolism; D010588:Phagosomes / Q000378:metabolism; D016062:Porosity; D012825:Silicon / Q000008:administration & dosage* / Q000737:chemistry; D017550:Spectroscopy, Fourier Transform Infrared
chemical_list: D004337:Drug Carriers; D005290:Ferric Compounds; C000499:ferric oxide; D012825:Silicon
references.citation: Biomaterials. 2008 Jan;29(3):377-84
references.pmid: 17936897
references.citation: Biomaterials. 2009 May;30(13):2440-8
references.pmid: 19215978
references.citation: EMBO J. 2007 Jan 24;26(2):313-24
references.pmid: 17245426
references.citation: Nat Nanotechnol. 2008 Mar;3(3):151-7
references.pmid: 18654487
references.citation: Pharm Res. 2003 Feb;20(2):212-20
references.pmid: 12636159
references.citation: Trends Biotechnol. 2010 Apr;28(4):181-8
references.pmid: 20079548
references.citation: Int J Nanomedicine. 2006;1(2):117-28
references.pmid: 17722528
references.citation: Bioconjug Chem. 2006 Jul-Aug;17(4):943-9
references.pmid: 16848401
references.citation: Biochem J. 1998 Dec 1;336 ( Pt 2):271-82
references.pmid: 9820800
references.citation: Small. 2008 May;4(5):577-82
references.pmid: 18383444
references.citation: Nat Rev Cancer. 2005 Mar;5(3):161-71
references.pmid: 15738981
references.citation: J Am Chem Soc. 2007 Mar 21;129(11):3333-8
references.pmid: 17319667
references.citation: Biomacromolecules. 2001 Winter;2(4):1161-8
references.pmid: 11777388
references.citation: Nanoscale. 2009 Nov;1(2):250-9
references.pmid: 20644846
references.citation: Adv Drug Deliv Rev. 2006 Dec 1;58(14):1532-55
references.pmid: 17092599
references.citation: J Cell Sci. 1998 Feb;111 ( Pt 3):303-12
references.pmid: 9427679
references.citation: Curr Vasc Pharmacol. 2004 Jul;2(3):281-99
references.pmid: 15320826
references.citation: Biomaterials. 2010 Jan;31(1):173-9
references.pmid: 19783034
references.citation: J Biol Chem. 1996 Feb 16;271(7):3803-11
references.pmid: 8631997
references.citation: Mol Cell Biol. 2003 Sep;23(18):6494-506
references.pmid: 12944476
references.citation: FASEB J. 2002 Aug;16(10):1217-26
references.pmid: 12153989
references.citation: Cytometry A. 2009 Sep;75(9):752-60
references.pmid: 19610127
references.citation: Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3878-82
references.pmid: 12644705